Back to Dashboard
OSUR · Healthcare

Orasure Technologies Inc

USA Healthcare Filing: 2026-06-30
21/100
Smart-money confidence
Bottom band — money moving out

No standout activity across the feeds we track.

Stocks scoring 0–25 beat the S&P 500 39.9% of the time over the next three months, since 2015. How we measured this →

6
hedge funds
hold it · 3 added, 3 trimmed
Cross-source blend of hedge-fund breadth, Congress trades, and insider Form 4s.  ·  how the score works
Market cap
$239M
Industry
Medical Instruments & Supplies
Sector
Healthcare
Exchange
NasdaqGS
About ORASURE TECHNOLOGIES INC

OraSure Technologies, Inc., together with its subsidiaries, develops, manufactures, markets, sells, and distributes diagnostic products and specimen collection devices in the United States, Europe, Africa, and internationally. It offers OraQuick Rapid HIV test, OraQuick HIV self-test, OraQuick HIV self-test(international), OraQuick HCV rapid antibody test and self-test, Syphilis health check rapid diagnostic test, OraQuick Ebola rapid antigen test, InteliSwab COVID-19 rapid test, InteliSwab COVID-19 rapid test pro, InteliSwab COVID-19 rapid test rx, SickleSCAN test, and OraSure oral fluid…

Who's behind the signal
Every informed buyer we can see on OSUR, across all three feeds.
Hedge funds · 6
Citadel Advisors Increased +84%
Renaissance Technologies Decreased −3%
D.E. Shaw & Co Decreased −40%
AQR Capital Management Decreased −3%
Congress · 1
Insiders
No significant Form 4 insider activity in the window.
Congressional trades · 2 on record
Disclosures from 2020-10-08 to 2021-02-23
The newest disclosure we hold for this stock is 2021-02-23. That is the end of our data, not necessarily the end of the trading — our bulk STOCK Act archive stops there and newer filings arrive through a separate live feed. Treat the absence of recent rows as “not covered”, not as “no trades”.
Trade date Member Chamber Action Amount
2021-02-23 Tom Malinowski · D-NJ House Sold $15,001 - $50,000
2020-10-08 Tom Malinowski · D-NJ House Sold $1,001 - $15,000
Not a model pick — but on our radar. ORASURE TECHNOLOGIES INC isn't in the top-10 model right now, but 6 tracked investors hold it. Everything below is real signal from public filings — treat this as a watch candidate, not a conviction call.
6
Investors
0
New positions
3
Increasing
3
Decreasing
0
Unchanged
Price History
Loading price data...
Ctrl/⌘ + scroll or pinch to zoom · drag to measure · double-click to reset Pinch to zoom · drag sideways to move through time
A member of Congress bought A member sold
Return: High: Low:

Markers sit on the transaction date the member disclosed, snapped to the nearest close on the chart. They are not the date the public found out — that came later, and the gap is its own page. Every marker is listed by name in the table above.

Who's Holding This Stock
Position sizes and recent activity from tracked institutional investors
Portfolio Allocation
How much of each investor's portfolio is allocated to ORASURE TECHNOLOGIES INC
⚠ Disclaimer: This page is for informational purposes only. Holdings data from SEC EDGAR 13F filings, delayed up to 135 days. Not a recommendation to buy or sell ORASURE TECHNOLOGIES INC or any security.

Get the Weekly Update

Every week, we'll send you what Buffett, Dalio, Ackman and 47 other legendary investors are buying — free, straight from their SEC filings.
Free forever · No spam · Unsubscribe anytime · Privacy